UK’s NICE Backs Two Microsphere Products For Liver Cancer But Says No To Another
Executive Summary
Health technology assessment body NICE has now recommended that selective internal radiation therapy can be used on England’s National Health Service for treating advanced liver cancer.
You may also be interested in...
Boston Scientific TheraSphere Liver Cancer Treatment Succeeds In EPOCH Trial
Results showed that patients were less likely to exhibit disease progression, or die, following treatment with beta-emitted microspheres.
In A First, FDA Approves Radioembolization Treatment For Liver Cancer In US
Approval for Boston Scientific’s TheraSphere offers further access to the therapy that, until now, has only been available under a humanitarian device exemption.
BMS & Pfizer Win Funding ‘Firsts’ In England For Migraine & Heart Disease Drugs
Bristol Myers Squibb and Pfizer both asked the health technology assessment body NICE to evaluate their respective drugs, Camzyos and Vydura, for use in indications that are narrower than those for which they are – or will potentially be – approved.